- ASO Author Reflections: Longitudinal Relief of Patient-Report Dysphagia in Esophageal CancerHuang, Shujie; Qiao, Guibin*Annals of Surgical Oncology, 2023.
- Induction immunochemotherapy conversion rate and survival outcomes versus chemotherapy in initially unresectable esophageal squamous cell carcinomaHuang, Shujie; Wang, Sichao; Gao, Zhen; Zeng, Ruijie; Xu, Wei; Tang, Yong; Tang, Jiming; Ben, Xiaosong; Zhang, Dongkun; Xie, Liang; Zhou, HaiYu; Chen, Gang; Fu, Junhui; Kong, Feng-Ming Spring; Qiao, GuibinAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.
- Validity of Meta-Analytical Estimates and Hazard Ratios Quantifying Survival Benefit of Immunochemotherapy in Low PD-L1-Expressing Esophageal Squamous Cell CarcinomaYu, Guo; Zhang, Na; Guan, Ai-Jia; Qiao, Yu-Wei; Li, Guo-Fu*Journal of Clinical Oncology, 2023, 41(15): 2862-+.被引 1
期刊论文
ASO Visual Abstract: Early and Persistent Dysphagia Relief Predicts Tumor Response in Esophageal Squamous Cell Carcinoma Patients Treated with Immunochemotherapy
1被引34阅读
